Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice.

Prasad V, Srirajaskanthan R, Toumpanakis C, Grana CM, Baldari S, Shah T, Lamarca A, Courbon F, Scheidhauer K, Baudin E, Truong Thanh XM, Houchard A, Dromain C, Bodei L.

Eur J Nucl Med Mol Imaging. 2020 Feb 15. doi: 10.1007/s00259-020-04712-2. [Epub ahead of print]

PMID:
32062681
2.

Current Biomedical Use of Copper Chelation Therapy.

Baldari S, Di Rocco G, Toietta G.

Int J Mol Sci. 2020 Feb 6;21(3). pii: E1069. doi: 10.3390/ijms21031069. Review.

3.

Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.

Baldari S, Di Rocco G, Magenta A, Picozza M, Toietta G.

Cells. 2019 Dec 3;8(12). pii: E1560. doi: 10.3390/cells8121560.

4.

Malignant Cutaneous Melanoma: Updates in PET Imaging.

Laudicella R, Baratto L, Minutoli F, Baldari S, Iagaru A.

Curr Radiopharm. 2020;13(1):14-23. doi: 10.2174/1874471012666191015095550.

PMID:
31749439
5.

Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation.

Minutoli F, Di Bella G, Mazzeo A, Laudicella R, Gentile L, Russo M, Vita G, Baldari S.

J Nucl Cardiol. 2019 Nov 18. doi: 10.1007/s12350-019-01950-2. [Epub ahead of print]

PMID:
31741327
6.

Intraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell- and Tissue-Based Therapies: Concise Review.

Trivisonno A, Alexander RW, Baldari S, Cohen SR, Di Rocco G, Gentile P, Magalon G, Magalon J, Miller RB, Womack H, Toietta G.

Stem Cells Transl Med. 2019 Dec;8(12):1265-1271. doi: 10.1002/sctm.19-0166. Epub 2019 Oct 10. Review.

7.

Internal dosimetry for TARE therapies by means of GAMOS Monte Carlo simulations.

Auditore L, Amato E, Italiano A, Arce P, Campennì A, Baldari S.

Phys Med. 2019 Aug;64:245-251. doi: 10.1016/j.ejmp.2019.07.024. Epub 2019 Aug 2.

PMID:
31515027
8.

18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis.

Laudicella R, Albano D, Alongi P, Argiroffi G, Bauckneht M, Baldari S, Bertagna F, Boero M, Vincentis G, Sole AD, Rubini G, Fantechi L, Frantellizzi V, Ganduscio G, Guglielmo P, Nappi AG, Evangelista L; on the behalf of Young AIMN Working Group.

Cancers (Basel). 2019 Sep 11;11(9). pii: E1348. doi: 10.3390/cancers11091348. Review.

9.

18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma.

Laudicella R, Davidzon G, Vasanawala S, Baldari S, Iagaru A.

Nucl Med Mol Imaging. 2019 Aug;53(4):296-299. doi: 10.1007/s13139-019-00597-8. Epub 2019 Jun 12.

PMID:
31456863
10.

Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study.

Trimboli P, Palermo A, Deandrea M, Piccardo A, Campennì A, Valabrega S, Grani G, Santolamazza G, Bottoni G, Barnabei A, Ramundo V, Lauretta R, Monte L, Ferrarazzo G, Paone G, Crosetto C, Ruggeri RM, Baldari S, Chiefari A, Vottari S, Giarnieri E, Perrella E, Limone P, Durante C, Giovanella L, Appetecchia M, Crescenzi A.

Endocrine. 2019 Dec;66(3):557-562. doi: 10.1007/s12020-019-02013-9. Epub 2019 Jul 16.

PMID:
31313225
11.

Comment on: "Technical note: Single time point dose estimate for exponential clearance" [Med. Phys. 45(5), 2318-2324 (2018)].

Amato E, Campennì A, Ruggeri RM, Auditore L, Baldari S.

Med Phys. 2019 Jun;46(6):2776-2779. doi: 10.1002/mp.13540. No abstract available.

PMID:
31187571
12.

Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.

Quartuccio N, Evangelista L, Alongi P, Caobelli F, Altini C, Cistaro A, Lambertini A, Schiorlin I, Popescu CE, Linguanti F, Laudicella R, Scalorbi F, Di Pierro G, Asabella AN, Cuppari L, Margotti S, Lima GM, Scalisi S, Pacella S, Kokomani A, Ciaccio A, Sturiale L, Vento A, Cardile D, Baldari S, Panareo S, Fanti S, Rubini G, Schillaci O, Chiaravalloti A; Young AIMN Working Group.

Nucl Med Commun. 2019 Aug;40(8):808-814. doi: 10.1097/MNM.0000000000001038.

PMID:
31136534
13.

Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells.

Baldari S, Di Rocco G, Heffern MC, Su TA, Chang CJ, Toietta G.

Cancers (Basel). 2019 May 12;11(5). pii: E659. doi: 10.3390/cancers11050659.

14.

Prognostic insights of molecular imaging in cardiac sarcoidosis.

Laudicella R, Minutoli F, Baldari S.

J Nucl Cardiol. 2019 Apr 3. doi: 10.1007/s12350-019-01701-3. [Epub ahead of print] No abstract available.

PMID:
30945210
15.

Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience.

Giuffrida G, Ferraù F, Laudicella R, Cotta OR, Messina E, Granata F, Angileri FF, Vento A, Alibrandi A, Baldari S, Cannavò S.

Endocr Connect. 2019 May 1;8(5):528-535. doi: 10.1530/EC-19-0065.

16.

Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose.

Campennì A, Amato E, Laudicella R, Alibrandi A, Cardile D, Pignata SA, Trimarchi F, Ruggeri RM, Auditore L, Baldari S.

Endocrine. 2019 Jul;65(1):132-137. doi: 10.1007/s12020-019-01897-x. Epub 2019 Mar 14.

PMID:
30875058
17.

Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development.

Sarogni P, Palumbo O, Servadio A, Astigiano S, D'Alessio B, Gatti V, Cukrov D, Baldari S, Pallotta MM, Aretini P, Dell'Orletta F, Soddu S, Carella M, Toietta G, Barbieri O, Fontanini G, Musio A.

J Exp Clin Cancer Res. 2019 Mar 1;38(1):108. doi: 10.1186/s13046-019-1116-0.

18.

Comment on: Lack of association between obesity and aggressiveness of differentiated thyroid cancer.

Campennì A, Trimarchi F, Baldari S.

J Endocrinol Invest. 2019 Jan;42(1):107-108. doi: 10.1007/s40618-018-0970-5. Epub 2018 Oct 20. No abstract available.

PMID:
30343357
19.

Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells.

Di Rocco G, Baldari S, Pani G, Toietta G.

Cell Mol Life Sci. 2019 Jan;76(2):231-244. doi: 10.1007/s00018-018-2931-8. Epub 2018 Oct 10. Review.

20.

Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseases.

Di Rocco G, Baldari S, Gentile A, Capogrossi M, Toietta G.

Stem Cell Res Ther. 2018 Sep 26;9(1):250. doi: 10.1186/s13287-018-0986-y.

Supplemental Content

Loading ...
Support Center